Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000
Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000
Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000
Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000
Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000
Low-Molecular-Weight heparins and Heparinoids in Acute ischemic Stroke
Stroke 31:1770-1778, Bath,P.M.W. et al, 2000
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000
Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000
Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000
Primary Stenting for High-Grade Basilar Artery Stenosis
AJNR 21:1744-1749, Phatouros,C.C.,et al, 2000
Thrombolytic Therapy in Patients with Acute Ischemic Stroke
Arch Neurol 57:1430-1436, Hinchey,J.A. & Benesch,C., 2000
Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000
Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000
Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000
Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000
Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000
Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000
North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000
Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000
Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000
Special Report: Complications of Lumbar Puncture and Their Prevention with Atraumatic Lumbar Puncture Needles
Medscape:e7-e11, Evans,R.W., 2000
Efficient Operation of a High-Volume Anticoagulation Clinic
Am J Health Syst Pharm 56:443-449, Foss,M.T.,et al, 1999
Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine Use,A Report of 3 Cases and Review of the Literature
Arch Int Med 159:311-314, Chen,D.K.,et al,, 1999
CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999
Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999
Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999
Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999
Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999
Randomized,Placebo-Controlled Trial of Anticoagulant Treatment with Low-Molecular-Weight Heparin for Cerebral Sinus Thrombosis
Stroke 30:484-488,481, de Bruijn,S.F.T.M.,et al, 1999
Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999
Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999